Cetuximab API Manufacturers

Wiki Information	Cetuximab API Manufacturers
Indication & Benefits	Cetuximab indicated for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. It is indicated for treating a recurrent locoregional disease or metastatic squamous cell carcinoma of the head and neck in combination with platinum-based therapy with fluorouracil. It is indicated for recurrent or metastatic squamous cell carcinoma of the head and neck progressing after platinum-based therapy.
How To Use
Deficiency
Recommended For Better
Pregnancy Warning
Side Effects
Disclaimer	Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement.
Products